Already in 2005, in a pioneering study published by the team of Jérôme Galon, it was demonstrated that the accumulation of early memory and effector memory CD8+ T cells in the tumors of CRC patients correlated significantly with an improved clinical outcome (absence of early metastatic invasion, a less advanced pathological stage, and increased survival) [5]. Here, CD8A is linked to colorectal carcinoma.